Physician profile
James Morgan
NPI 1124019401
$21,031.09
in general payments reported to CMS, 2019-2025
27 companies · $836 in 2025
The $836 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $508 · 2021: $471 · 2022: $2,581 · 2023: $13K · 2024: $3,332 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,900 · Travel and Lodging: $6,733 · Food and Beverage: $2,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,900.00 |
| Travel and Lodging | $6,732.55 |
| Food and Beverage | $2,475.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $15,594.01 | 2022-2025 | |
| Stryker Corporation | $2,298.04 | 2021-2025 | Hoffmann, Salvation, Augment Injectable |
| Treace Medical Concepts, INC. | $1,032.90 | 2022-2025 | |
| Horizon Therapeutics Plc | $317.84 | 2020-2022 | |
| Smith+Nephew, INC. | $294.82 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $265.96 | 2020-2021 | |
| Nevro Corp. | $202.57 | 2021-2024 | Senza |
| Globus Medical, INC. | $166.65 | 2025 | Senza |
| Paragon 28, INC. | $135.30 | 2021 | |
| Paratek Pharmaceuticals, INC. | $119.19 | 2019-2021 | |
| Wright Medical Technology, INC. | $82.24 | 2019 | |
| Convatec INC. | $62.09 | 2024-2025 | |
| Bioventus LLC | $61.90 | 2022 | |
| Kerecis Limited | $42.95 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Pfizer INC. | $41.97 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40.70 | 2019 | |
| Grt US Holding, INC. | $39.12 | 2022 | |
| Arbor Pharmaceuticals, INC. | $36.32 | 2021 | |
| Medtronic, INC. | $35.25 | 2021-2022 | |
| Organogenesis INC. | $34.80 | 2025 | Puraply Wound Matrix, Affinity |
| Boston Scientific Corporation | $25.94 | 2019 | |
| Orthofix Medical, INC. | $22.68 | 2024 | Physio-Stim |
| Ossio INC | $17.57 | 2023 | |
| Coopersurgical, INC. | $17.45 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.10 | 2019 | |
| Misonix INC | $14.10 | 2019 | |
| Sebela Pharmaceuticals INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.